The study focused on the application of high-resolution mass spectrometry for the identification of impurities in pharmaceutical small molecules. A high-performance liquid chromatography (HPLC) coupled high resolution mass spectrometer (HRMS) was used for identification of oxidative degradation impurities (DIs) of lansoprazole. The utilization of HRMS facilitates to determine the accurate mass of impurities and their fragment/product ions. A fast mass spectrometer (MS) compatible reverse phase chromatography method was used to investigate the oxidative stressed impurities. HPLC column; C18 (50 × 4.6 mm, 3.5 μm) was used with gradient elution. Spectral data acquired using information dependent acquisition (IDA) with real time dynamic background subtraction algorithm (DBS). Three oxidative impurities: DI-I (m/z 386.0781), DI-II (m/z 402.0734) and DI-III (m/z 386.0785), was observed during this study; interpretation of high resolution spectral data of all three impurities was carried out; elemental composition and molecular structure was proposed for major fragments. In this study mass error was found ≤7.7 parts per million (ppm).
References
[1]
Smith, R.J. and Webb, M.L. (2007) Analysis of Drug Impurities. Blackwell Publishing, Hoboken. https://doi.org/10.1002/9780470988749
[2]
ICH Expert Working Group (2006) Impurities in New Drug Substance ICH Q3A (R2) Current Step 4 Version.
[3]
ICH Expert Working Group (2006) Impurities in New Drug Products ICH Q3B (R2) Current Step 4 Version.
[4]
ICH Expert Working Group (2003) Stability Testing of New Drug Substances and Drug Products ICH Q1A (R2) Current Step 4 Version.
[5]
Willoughby, R.C., Sheehan, S.E.D. and Mitrovich, S. (2002) A Global View of LC/MS: How to Solve Your Most Challenging Analytical Problems. 2nd Edition, Global View Publishing, Pittsburgh.
[6]
Pramanik, B.N., Bartner, P.L. and Chen, G. (1999) The Role of Mass Spectrometry in the Drug Discovery Process. Current Opinion in Drug Discovery & Development, 2, 401-417.
[7]
Andrews, G.L., Simons, B.L., Young, J.B., Hawkridge, A.M. and Muddiman, D.C. (2011) Performance of a New Hybrid Quadrupole Time-of-Flight Tandem Mass Spectrometer (Triple TOF 5600). Analytical Chemistry, 83, 5442-5446.
https://doi.org/10.1021/ac200812d
[8]
Kumar, A., Darekar, G., Ramagiri, S., Bhasin, N., Pillai, M. and Shandilya, D.K. (2015) Generic Workflow Using Advanced Analysis and Data Interpretation Tools for Identification of Irbesartan Degradation Products by Liquid Chromatography to High Resolution Mass Spectrometry. ACAIJ, 15, 352-363.
[9]
Pillai, M.G., Kumar, A., Sharma, R. and Bhasin, N. (2014) LC-MS Based Workflows for Qualitative and Quantitative Analysis for Homeopathic Preparation of Hydrastis Canadensis. Chromatographia, 77, 119-131.
https://doi.org/10.1007/s10337-013-2577-5
[10]
Modhave, D.T., Handa, T., Shah, R.P. and Singh, S. (2011) Stress Degradation Studies on Lornoxicam Using LC, LC–MS/TOF and LC-MSn. Journal of Pharmaceutical and Biomedical Analysis, 56, 538-545. https://doi.org/10.1016/j.jpba.2011.06.012
[11]
Ragu, B., Ramesh, M., Srinivas, R., Satyanarayana Raju, S. and Venkateswarlu, Y. (2011) Identification and Characterization of Stressed Degradation Products of Prulifloxacin Using LC–ESI-MS/Q-TOF, MSn Experiments: Development of a Validated Specific Stability-Indicating LC-MS Method. Journal of Pharmaceutical and Biomedical Analysis, 56, 560-568. https://doi.org/10.1016/j.jpba.2011.06.021
[12]
Wikipedia (2017) Lansoprazole. https://en.wikipedia.org/wiki/Lansoprazole
Rao, P.V. and Kumar, M.N. (2013) A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and Its Impurities in Bulk Drug and Pharmaceutical Dosage Forms. Scientia Pharmaceutica, 81, 183-193.
https://doi.org/10.3797/scipharm.1210-09
[17]
Battu, S. and Pottabathini, V. (2015) Hydrolytic Degradation Study of Lansoprazole, Identification, Isolation and Characterization of Base Degradation Product. American Journal of Analytical Chemistry, 6, 145-155.
https://doi.org/10.4236/ajac.2015.62013
[18]
Luo, Y., Xu, Li., Xu, M., Feng, J. and Tang X. (2012) A Validated, Specific, Stability-Indicating HPLC Method for Determination of Lansoprazole Enteric Capsules and Related Impurities. Asian Journal of Pharmaceutical Sciences, 7, 149-154.
[19]
Shandilya, D.K., Joseph, P.E. and Kantamreddi, V.S.S. (2017) Interpretation of Full Scan Atmospheric Pressure Ionization Mass Spectra (MS) and Collision Induced Dissociation Fragmentation Spectra (MS/MS) of Small Organic Molecules—A Mini Review. Systematic Reviews in Pharmacy, 8, 23-25.
https://doi.org/10.5530/srp.2017.1.9
[20]
Shandilya, D.K., Joseph, P.E. and Kantamreddi, V.S.S. (2017) Prediction of the Fragmentation Pathway of Atorvastatin by Using High Resolution Collision Induced Dissociation (HR-MS/MS) Spectral Data. Open Access Library Journal, 4, e3473. https://doi.org/10.4236/oalib.1103473
[21]
Blanc Le Yves, J.C. and Bloomfleld, N. Real Time Dynamic Background Subtraction: Improving the Automated Ion Selection Process. Technical Note, Applied Biosystem.
